Statistics
Publications
2
Citations
49
H-Index
2
Active since
2019
Affiliations
NHO Kinki Chuo Chest Medical Center(Current)
Kazunori Moriizumi is an author at NHO Kinki Chuo Chest Medical Center specializing in oncology, medicine, and checkpoint inhibitor therapy.
Publications per year
2019–2020
2
2
Which Is Better EGFR-TKI Followed by Osimertinib: Afatinib or Gefitinib/Erlotinib?
Motohiro Tamiya, Akihiro Tamiya, Hidekazu Suzuki et al. · Anticancer Research · 2019 · 30 citations · Full text
Medicine, Oncology, Pharmacology +15
Pembrolizumab-Induced Delayed-Onset Hepatitis
Kensuke Kanaoka, Kazunori Moriizumi, Hideyasu Okada et al. · Case Reports in Gastroenterology · 2020 · 19 citations · Full text
1–2 of 2